InMode (STU:154) Moat Score: 5/10 (As of Jul. 08, 2026)


STU:154 InMode Ltd STU:154
81 GF Score
Price €12.71
GF Value €17.07
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is InMode Moat Score?

InMode STU:154 -0.47% 81 Moat Score is 5 as of Jul. 08, 2026. GuruFocus rates STU:154 with a GF Score™ of 81/100 and a GF Value™ of €17.07 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 844 Medical Devices & Instruments companies, InMode ranks better than 91.23% on this metric.

InMode has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

InMode has Narrow Moat: InMode Ltd has a solid narrow moat due to its proprietary technology and strong brand in the medical aesthetics market. The company benefits from economies of scale and consistent innovation, but lacks significant regulatory barriers and network effects to elevate it to a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes InMode might have Narrow Moat - Solid narrow moat.

InMode  (STU:154) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

InMode Moat Score Related Terms

STU:154 vs SIBN, CBLL, BBNX: Moat Score Comparison

For the Medical Devices subindustry, InMode's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InMode Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InMode's Moat Score distribution charts can be found below:

* The bar in red indicates where InMode's Moat Score falls into.


STU:154
81GF Score
InMode Ltd STU:154
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
InMode (STU:154) has a Moat Score of 5 as of Jul. 08, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, InMode ranks #74 out of 844 companies in the Medical Devices & Instruments industry, placing it in the top 8.8%.
Is InMode's Moat Score too high?
InMode's current Moat Score is 5. Based on the distribution chart, InMode ranks #74 out of 844 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, InMode has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does InMode's Moat Score compare to SIBN and CBLL?
According to the Medical Devices & Instruments industry distribution chart, InMode ranks #74 out of 844 companies for Moat Score. This places InMode in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. InMode's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InMode stock overvalued right now?
Based on GuruFocus' analysis, InMode (STU:154) is currently considered Modestly Undervalued. The stock's GF Value™ is €17.07, compared to a current price of €12.71 — trading 25.5% below its estimated fair value. The current Moat Score is 5. InMode's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For InMode (STU:154), the current Moat Score is 5 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InMode (STU:154) Overvalued in 2026?

Based on GuruFocus' analysis, InMode stock appears to be undervalued. The current stock price of €12.71 is trading 25.5% below its estimated GF Value™ of €17.07. GuruFocus considers InMode to be Modestly Undervalued.

Key valuation signals for STU:154:

  • Moat Score: 5
  • GF Value™: €17.07 vs. price of €12.71 (25.5% below fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the STU:154 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

InMode Business Description

Other Exchanges INMD:USA
Address Sha’ar Yokneam, Tavor Building, P.O. Box 533, Yokneam, ISR, 2069206
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
81GF Score

Get the complete analysis for STU:154

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.71
Price
€17.07
GF Value